COVID-19-associated fungal infections

M Hoenigl, D Seidel, R Sprute, C Cunha… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Tackling the emerging threat of antifungal resistance to human health

MC Fisher, A Alastruey-Izquierdo, J Berman… - Nature reviews …, 2022 - nature.com
Invasive fungal infections pose an important threat to public health and are an under-
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …

Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment

J Rhodes, A Abdolrasouli, K Dunne, TR Sewell… - Nature …, 2022 - nature.com
Infections caused by the fungal pathogen Aspergillus fumigatus are increasingly resistant to
first-line azole antifungal drugs. However, despite its clinical importance, little is known …

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

PE Verweij, RJM Brüggemann, E Azoulay… - Intensive care …, 2021 - Springer
Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

Coronavirus disease 2019–associated invasive fungal infection

JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review

WH Chong, KP Neu - Journal of Hospital Infection, 2021 - Elsevier
Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

Understanding the role of bacterial and fungal infection in COVID-19

TM Rawson, RC Wilson… - Clinical …, 2021 - clinicalmicrobiologyandinfection …
The novel coronavirus disease (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed an unprecedented strain on …

Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India

Y Mishra, M Prashar, D Sharma, VP Kumar… - Diabetes & Metabolic …, 2021 - Elsevier
Abstract Aims Diabetes Mellitus predisposes patients to invasive fungal infections. There
has been a recent surge of Mucormycosis with COVID 19 infection particularly in patients …

Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis

WH Chong, BK Saha, KP Neu - Infection, 2022 - Springer
Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

The consequences of our changing environment on life threatening and debilitating fungal diseases in humans

N Van Rhijn, M Bromley - Journal of Fungi, 2021 - mdpi.com
Human activities have significantly impacted the environment and are changing our climate
in ways that will have major consequences for ourselves, and endanger animal, plant and …